Gil D. Rabinovici

1 ta ish

University of California, San Francisco

1. Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

   Suzanne E. Schindler, Douglas Galasko, Ana C. Pereira +32

   Sharh maqola20242 iqtibos

   ABIABI:AkademIndex/2026.other.870812